Drug Interaction Report

Sertraline and Siponimod: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Sertraline

No brand names on record
+

Siponimod

Mayzent Mayzent®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 532 documented Sertraline interactions, 477 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Sertraline and siponimod can each affect heart rhythm, so together they may add up to a higher risk of QT prolongation. Do not change anything on your own; your care team can manage this with cardiology input and heart monitoring, especially when siponimod is started.

Both sertraline (an antidepressant) and siponimod (a multiple sclerosis medicine) can affect the heart's electrical timing, something called the QT interval. When two medicines that do this are taken together, the effect can add up and, in rare cases, lead to an abnormal heart rhythm.

Siponimod can also slow the heart rate, especially when you first start it, which is why doctors are extra careful. The good news is your care team knows how to handle this. They may check your heart with an EKG, watch you more closely at the start, or talk with a heart specialist. Please keep taking both exactly as prescribed and bring this up with your pharmacist or doctor.

Effect: Additive QT interval prolongation with potential arrhythmogenic risk when sertraline is combined with siponimod.

Mechanism: Pharmacodynamic (additive) QTc prolongation. Siponimod also causes transient bradycardia and AV conduction effects at initiation.

  • Direction: Additive PD effect; neither drug is a prodrug.
  • Evidence: Theoretical; magnitude not quantified.
  • Onset: Unspecified; siponimod cardiac effects are most pronounced during titration.

Management: Manufacturer advises against coadministration with QT-prolonging, arrhythmogenic agents. Involve cardiology regarding switching to non heart-rate-lowering therapy or appropriate first-dose monitoring (ECG, heart rate, electrolytes).

Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of QT interval prolongation

Interaction Deep Dive

Avoid giving siponimod together with QT prolonging agents that have recognized arrhythmogenic properties, since their effects on heart rate may be additive. When siponimod therapy is being contemplated, consult a cardiologist about either transitioning to medications that do not lower heart rate or arranging suitable monitoring at the start of treatment1.

Why it happens (mechanism)

Additive QT interval prolongation

How to manage this interaction

Keep taking both medicines as prescribed unless your care team tells you otherwise. This combination can be managed with the right precautions.

  • Your care team may involve a cardiologist, especially when siponimod is being started.
  • They may consider whether a different (non heart-rate-lowering) option is appropriate, or arrange closer heart monitoring such as an EKG at treatment initiation.
  • Tell your pharmacist or doctor about any fainting, dizziness, palpitations, or a slow or irregular heartbeat.
  • Share your full medication list so any other QT-affecting drugs are accounted for.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Sertraline and Siponimod together?

Sertraline and siponimod can each affect heart rhythm, so together they may add up to a higher risk of QT prolongation. Do not change anything on your own; your care team can manage this with cardiology input and heart monitoring, especially when siponimod is started. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Sertraline and Siponimod interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Sertraline and Siponimod interaction managed?

Keep taking both medicines as prescribed unless your care team tells you otherwise. This combination can be managed with the right precautions. Your care team may involve a cardiologist, especially when siponimod is being started. They may consider whether a different (non heart-rate-lowering) option is appropriate, or arrange closer heart monitoring such as an EKG at treatment initiation. Tell yo… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Sertraline or Siponimod need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: MAYZENT(R) oral tablets, siponimod oral tablets. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2019. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.